Facet browsing currently unavailable
Page 1 of 1 results
Sort by: relevance publication year
Showing DOI matching
10.1016/S1470-2045(11)70081-X
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study JOURNAL ARTICLE published May 2011 in The Lancet Oncology |